Schedule 13G ownership disclosure
Horizon Pharma plc
Security class unavailable · CUSIP: G4617B105
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 15,600,988
- Percent of class
- 9.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-16-005880
- Form type
- SC 13G
- Filer
- Horizon Therapeutics Public Ltd Co
- CIK
- CIK 1492426
- Filed
- Feb 16, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership